109 related articles for article (PubMed ID: 38246220)
1. HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer.
Wu QN; Qi J; Liu ZK; Luo XJ; Yu K; Lu YX; Wang Y; Jin Y; Liu J; Huang LY; Zeng ZL; Zheng Y; Xu RH; Liu ZX
Cancer Lett; 2024 Mar; 584():216643. PubMed ID: 38246220
[TBL] [Abstract][Full Text] [Related]
2. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.
Liu WG; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7905-7912. PubMed ID: 31599413
[TBL] [Abstract][Full Text] [Related]
4. Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma.
Xiao W; Wang T; Ye Y; Wang X; Chen B; Xing J; Yang H; Zhang X
Aging (Albany NY); 2021 Jan; 13(3):3536-3553. PubMed ID: 33495417
[TBL] [Abstract][Full Text] [Related]
5. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway.
Xiao F; Ouyang B; Zou J; Yang Y; Yi L; Yan H
Drug Dev Res; 2020 Aug; 81(5):544-550. PubMed ID: 32096264
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0025202 suppresses cell tumorigenesis and tamoxifen resistance via miR-197-3p/HIPK3 axis in breast cancer.
Li H; Li Q; He S
World J Surg Oncol; 2021 Feb; 19(1):39. PubMed ID: 33536026
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA HIPK3 promotes glioma progression by binding to miR-124-3p.
Hu D; Zhang Y
Gene; 2019 Mar; 690():81-89. PubMed ID: 30576808
[TBL] [Abstract][Full Text] [Related]
9. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation.
Rochat-Steiner V; Becker K; Micheau O; Schneider P; Burns K; Tschopp J
J Exp Med; 2000 Oct; 192(8):1165-74. PubMed ID: 11034606
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.
Tang X; Liang Y; Sun G; He Q; Hou Z; Jiang X; Gao P; Qu H
Cell Death Dis; 2022 Oct; 13(10):848. PubMed ID: 36195596
[TBL] [Abstract][Full Text] [Related]
11. JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis.
Li S; Wei Y; Sun X; Liu M; Zhu M; Yuan Y; Zhang J; Dong Y; Hu K; Ma S; Zhang X; Xu B; Jiang H; Gan L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1784-1796. PubMed ID: 37337631
[TBL] [Abstract][Full Text] [Related]
12. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
[TBL] [Abstract][Full Text] [Related]
13. Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
Takashima T; Taniyama D; Sakamoto N; Yasumoto M; Asai R; Hattori T; Honma R; Thang PQ; Ukai S; Maruyama R; Harada K; Kuraoka K; Tanabe K; Sasaki AT; Ohdan H; Morii E; Murai J; Yasui W
Br J Cancer; 2021 Jul; 125(1):65-77. PubMed ID: 33785877
[TBL] [Abstract][Full Text] [Related]
14. TOPBP1 regulates resistance of gastric cancer to oxaliplatin by promoting transcription of PARP1.
Fang Z; Gong C; Ye Z; Wang W; Zhu M; Hu Y; Liu Z; Zhou W; Li H
DNA Repair (Amst); 2022 Mar; 111():103278. PubMed ID: 35124372
[TBL] [Abstract][Full Text] [Related]
15. Circ_0001052 promotes cardiac hypertrophy via elevating Hipk3.
Yang M; Wang W; Wang L; Li Y
Aging (Albany NY); 2023 Feb; 15(4):1025-1038. PubMed ID: 36800233
[TBL] [Abstract][Full Text] [Related]
16. miR-15a-5p targets PHLPP2 in gastric cancer cells to modulate platinum resistance and is a suitable serum biomarker for oxaliplatin resistance.
Pang K; Song J; Bai Z; Zhang Z
Neoplasma; 2020 Sep; 67(5):1114-1121. PubMed ID: 32567934
[TBL] [Abstract][Full Text] [Related]
17. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA
Chen X; Mao R; Su W; Yang X; Geng Q; Guo C; Wang Z; Wang J; Kresty LA; Beer DG; Chang AC; Chen G
Autophagy; 2020 Apr; 16(4):659-671. PubMed ID: 31232177
[TBL] [Abstract][Full Text] [Related]
19. Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.
Kong F; Sun T; Kong X; Xie D; Li Z; Xie K
Clin Cancer Res; 2018 May; 24(10):2440-2451. PubMed ID: 29367428
[No Abstract] [Full Text] [Related]
20. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
